000 | 01308 a2200385 4500 | ||
---|---|---|---|
005 | 20250513123741.0 | ||
264 | 0 | _c19970929 | |
008 | 199709s 0 0 eng d | ||
022 | _a0362-5664 | ||
024 | 7 |
_a10.1097/00002826-199708000-00008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDeutsch, S I | |
245 | 0 | 0 |
_aMethylene blue adjuvant therapy of schizophrenia. _h[electronic resource] |
260 |
_bClinical neuropharmacology _cAug 1997 |
||
300 |
_a357-63 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aGuanylate Cyclase _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethylene Blue _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
650 | 0 | 4 | _aPsychiatric Status Rating Scales |
650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
650 | 0 | 4 | _aSchizophrenic Psychology |
700 | 1 | _aRosse, R B | |
700 | 1 | _aSchwartz, B L | |
700 | 1 | _aFay-McCarthy, M | |
700 | 1 | _aRosenberg, P B | |
700 | 1 | _aFearing, K | |
773 | 0 |
_tClinical neuropharmacology _gvol. 20 _gno. 4 _gp. 357-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002826-199708000-00008 _zAvailable from publisher's website |
999 |
_c9240357 _d9240357 |